St. Jude Children’s Research Hospital in Memphis, Tennessee, will install the Hitachi Proton Beam Therapy (PBT) system at its facility to treat cancer patients.
The radiation therapy is capable of spot scanning tumours and is about 40% smaller than a traditional radiotherapy solution.
The spot scanning technology is designed to facilitate more accurate irradiation without affecting the healthy tissues surrounding the tumour compared with traditional double scattering irradiation.
The PBT system is expected to allow adults and children to continue with their normal daily activities while undergoing out-patient treatment.
The system will be deployed at an upcoming facility which will feature three treatment rooms, two with rotating gantry systems and one with a fixed horizontal beam.
The proton therapy system is expected to become operational in 2015.
St. Jude Children’s Research Hospital CEO Dr. William Evans said that by bringing the technology to the campus, the hospital will become the first centre in the country to offer the therapy solely for the purpose of treating children with brain tumours and other paediatric cancers.
"Currently, we ensure our patients needing this therapy receive it through collaboration with other institutions, but having the technology available here at St. Jude will enable a new level of service and convenience for our patients," Evans added.
"In addition, it takes advantage of recent advances in the technology and will allow integration with our cutting-edge research programmes."
Tatsuro Ishizuka, vice president and executive officer, president and CEO of Power Systems Company, Hitachi, said that the company’s expertise in accelerators, irradiation and control systems played a key role in the development and refinement of the PBT system.
As part of the agreement, the company will maintain the PBT system for ten years after the deployment of the system.